Pharmacodynamics, pharmacokinetics and safety of revefenacin (TD-4208), a long-acting muscarinic antagonist, in patients with chronic obstructive pulmonary disease (COPD): Results of two randomized, double-blind, phase 2 studies
Keywords: یک بار روزانه; Bronchodilator; COPD; Long-acting muscarinic antagonist; Revefenacin; Rapid onset; Nebulized; Once-daily; Inhalation; Anti-muscarinic;